Portola stock shoots higher after FDA approval
Portola Pharmaceuticals Inc. shares jumped Monday after the company announced that the Food and Drug Administration had given an approval that should lead to the launch of its Andexxa drug. Portola's stock was halted ahead of the news, then jumped about 13% after trading resumed at 3:40 p.m. Eastern time. Portola said the FDA had approved a "prior approval supplement" for Andexxa, "allowing for broad commercial launch in the United States," according to the announcement. Andexxa is a drug used... Читать дальше...